Metastatic Adenocarcinoma of the Lung

EP. 1: Importance of Molecular Testing in Lung Cancer

March 18th 2016

EP. 2: Practical Advice on Molecular Testing in Lung Cancer

March 18th 2016

EP. 3: PD-L1 Testing in Advanced Lung Cancer

March 18th 2016

EP. 4: The Future of Biomarker Testing in Lung Cancer

March 18th 2016

EP. 5: Chemotherapy for Advanced Lung Cancer

March 18th 2016

EP. 6: Second-Line Therapies for Non-Driver NSCLC

March 18th 2016

EP. 7: Upfront EGFR-Targeted Therapy

March 18th 2016

EP. 8: Treatment of Relapsed EGFR-Mutant Adenocarcinoma

March 18th 2016

EP. 9: Emerging Agents for Advanced EGFR+ Lung Cancer

March 18th 2016

EP. 10: ALK-Positive Lung Cancer

March 18th 2016

EP. 11: Less Common Mutations in Lung Adenocarcinoma

March 18th 2016

EP. 12: Checkpoint Inhibitors in NSCLC

March 18th 2016

EP. 13: Immune-Related Response Criteria in NSCLC

March 18th 2016

EP. 14: Emerging Checkpoint Inhibitors for Lung Cancer

March 18th 2016

EP. 15: Combining and Sequencing Immunotherapies in NSCLC

March 18th 2016

x